ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC
Adviser information for ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC last updated from Form ADV on March 29th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
| Type of Organization | Limited Liability Company |
|---|---|
| Fiscal Year End | DECEMBER |
| Legal Location | Delaware, United States |
Employees
| Total Number of Employees | 0 |
|---|---|
| Investment Advisory/Research | 0 |
| Registered Broker-Dealer Representatives | 0 |
| Registered State Investment Advisers | 0 |
| Licensed Agents of an Insurance Company | 0 |
| No. of Firms/People that Solicit Clients | 0 |
RAUM
| Provides Management of Securities Portfolios | No |
|---|
Clients
| Type | Number | RAUM |
|---|---|---|
| Individuals | 0 | $0 |
| HNW Individuals | 0 | $0 |
| Banking or thrift institutions | 0 | $0 |
| Investment companies | 0 | $0 |
| Business development companies | 0 | $0 |
| Pooled investment vehicles | 0 | $0 |
| Pension and profit sharing plans | 0 | $0 |
| Charitable organizations | 0 | $0 |
| State or municipal gov entities | 0 | $0 |
| Other investment advisers | 0 | $0 |
| Insurance companies | 0 | $0 |
| Sovereign wealth funds and foreign official institutions | 0 | $0 |
| Corporations or other businesses | 0 | $0 |
| Other | 0 | $0 |
| Type | Number |
|---|---|
| No. of Non-RAUM Clients | 0 |
| No. of Non-U.S. Clients | 0 |
Services
| Advisory Services | – |
|---|---|
| Compensation | – |
| Other Business Activities | VENTURE CAPITAL FIRM |
Principal Office
300 TECHNOLOGY SQUARE8TH FLOOR
CAMBRIDGE
MA
United States
Monday - Friday, 8:00 AM - 5:00 PM
Tel: 857-201-2700, Fax: 857-201-2701
Websites
Chief Compliance Officer
NoneIndustry Affiliates
| ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P. | Sponsor, GP, manager of pooled investment vehicles |
| ATLAS VENTURE ASSOCIATES OPPORTUNITY II, L.P. | Sponsor, GP, manager of pooled investment vehicles |
| ATLAS VENTURE ASSOCIATES X, L.P. | Sponsor, GP, manager of pooled investment vehicles |
| ATLAS VENTURE ASSOCIATES XI, L.P. | Sponsor, GP, manager of pooled investment vehicles |
| ATLAS VENTURE ASSOCIATES XII, L.P. | Sponsor, GP, manager of pooled investment vehicles |
| ATLAS VENTURE ASSOCIATES XIII, L.P. | Sponsor, GP, manager of pooled investment vehicles |
Private Funds
| Name | Type | Assets $USD | Min Investment $USD | No. Owners |
|---|---|---|---|---|
| ATLAS VENTURE FUND X, L.P. | Venture Capital Fund | $406.4M | $0.5M | 37 |
| ATLAS VENTURE FUND XI, L.P. | Venture Capital Fund | $552.8M | $0.5M | 71 |
| ATLAS VENTURE FUND XII, L.P. | Venture Capital Fund | $434.5M | $0.5M | 86 |
| ATLAS VENTURE FUND XIII, L.P. | Venture Capital Fund | $535.4M | $0.5M | 87 |
| ATLAS VENTURE OPPORTUNITY FUND I, L.P. | Venture Capital Fund | $197.8M | $0.5M | 48 |
| ATLAS VENTURE OPPORTUNITY FUND II, L.P. | Venture Capital Fund | $286.2M | $0.5M | 70 |
Control Persons
| Name | Type | Entity | Title | Since | Ownership |
|---|---|---|---|---|---|
| BOOTH, BRUCE, LEE | Individual | – | MEMBER | 11/2014 | 10-25% |
| FORMELA, JEAN-FRANCOIS, BERNARD | Individual | – | MEMBER | 11/2014 | 10-25% |
| RHODES, JASON, PAUL | Individual | – | MEMBER | 11/2014 | 10-25% |
| GRAYZEL, DAVID | Individual | – | MEMBER | 11/2014 | 10-25% |
| CHOHAN, OMMER | Individual | – | CFO | 04/2015 | < 5% |
| Bitterman, Kevin | Individual | – | MEMBER | 06/2017 | 10-25% |
| Michael, Gladstone | Individual | – | MEMBER | 07/2020 | 10-25% |
No. Employees, Historic
Holdings
From latest 13F, filed August 8th, 2024 for period ending June 30th, 2024
| Name | Class | Value $USD | # Shares | Private Fund |
|---|---|---|---|---|
| Aerovate Therapeutics, Inc. | Common Stock | 3M | 2M | – |
| Day One Biopharmaceuticals, Inc. | Common Stock | 89M | 6M | – |
| Dianthus Therapeutics, Inc. | Common Stock | 4M | 137K | – |
| Disc Medicine, Inc. | Common Stock | 113M | 3M | – |
| Dyne Therapeutics, Inc. | Common Stock | 283M | 8M | – |
| Generation Bio, Co. | Common Stock | 23M | 8M | – |
| Ikena Oncology, Inc. | Common Stock | 8M | 5M | – |
| Korro Bio, Inc. | Common Stock | 39M | 1M | – |
| Kymera Therapeutics, Inc. | Common Stock | 160M | 5M | – |
| Q32 Bio, Inc. | Common Stock | 38M | 2M | – |
| Replimune Group, Inc. | Common Stock | 19M | 2M | – |
| Spero Therapeutics, Inc. | Common Stock | 696K | 535K | – |
| Tectonic Therapeutics, Inc. | Common Stock | 6M | 378K | – |
| Third Harmonic Bio, Inc. | Common Stock | 142M | 11M | – |
| Vigil Neuroscience, Inc. | Common Stock | 23M | 6M | – |